Thymus irradiation for myasthenia gravis.

Area of Science:

• Neurology
• Oncology

Background:

• Myasthenia gravis is a chronic autoimmune neuromuscular disease.
• Thymoma is a common cause of myasthenia gravis, but this study excluded patients with thymoma.

Purpose of the Study:

• To evaluate the efficacy of mediastinal irradiation in patients with myasthenia gravis without thymoma.
• To determine the duration of remission and factors influencing it.

Main Methods:

• Twenty-eight patients with progressive myasthenia gravis (24 generalized, 4 ocular) without thymoma received 3000 rads (30 Gy) of radiation to the anterior mediastinum.
• Follow-up ranged from five to 18 years.

Main Results:

• Twenty out of 24 patients with generalized myasthenia gravis improved post-treatment, with a median remission duration of 1.5 years.
• Four patients with generalized myasthenia gravis died during the post-treatment period.
• Patients with ocular myasthenia gravis showed no significant change after irradiation.
• Older patients tended to have longer remission periods compared to younger patients.

Conclusions:

• Mediastinal irradiation can induce temporary remission in generalized myasthenia gravis.
• The treatment appears less effective for ocular myasthenia gravis.
• Age is a potential factor influencing the duration of remission in generalized myasthenia gravis.